Home › Stocks › Cipla

Cipla is one of India's top pharmaceutical companies and a Nifty 50 constituent with strong presence in both domestic and US generic markets.

About Cipla

Cipla is one of India's largest pharmaceutical companies with a strong presence in respiratory, anti-infective, and cardiovascular drugs. It has significant US generics business and is sensitive to USFDA approvals, India domestic formulation growth, and branded generic pricing in emerging markets.

How to Screen CIPLA on BottomStreet

BottomStreet screens CIPLA as part of the broader Pharma sector and Nifty 50 universe. Use these screeners to find CIPLA in actionable setups:

Risk Management for Trading CIPLA

• CIPLA is a Nifty 50 constituent — always check the broader Nifty trend before entering a trade.
• Use a stop-loss on every trade. For intraday, place it below the opening range low or VWAP.
• Check F&O data before swing trades — rising futures OI with rising price confirms institutional conviction.
• Limit position size to 5-10% of capital for large-cap stocks with lower volatility.

Other Pharma Stocks